Czech Surgical Society
otherBrno, Czechia
Research output, citation impact, and the most-cited recent papers from Czech Surgical Society (Czechia). Aggregated across the NobleBlocks index of 300M+ scholarly works.
Top-cited papers from Czech Surgical Society
Chromian illite-magnesite-dolomite-quartz rock (listvenite-like) containing Ni-Co mineralization was found in the Svratka orthogneisses from the Dřínová quarry. The main rock-forming minerals are Fe-rich magnesite, Fe-rich dolomite, Cr-illite and quartz, less frequently calcite. Accessory minerals include chromite (with 0.841–0.886 apfu Fe2+ and 1.642–1.742 apfu Cr), gersdorffite-cobaltite (Ni0.45-0.92Fe0.01-0.34Co0.01-0.34As0.83-1.02Sb0.00-0.03S1), sulfides (pyrite, sphalerite), and apatite. The illite from the Dřínová quarry contains up to 3 wt. % of Cr2O3. Presence of the Cr-illite, accesory chromite, and Ni-Co sulfoarsenides represents origin from ultrabasic protolith, reflecting transformation to phyllosilicatecarbonate-quartz listvenite.
The question is: What is angiology? It is the branch of medical science studying blood and lymph vessels and their disorders. With the development of techniques, diagnostic and therapeutic methods and with the increasing morbidity and mortality on vascular diseases angiology became in the last decades an important specialization of medicine.
The Czech Society for Oncology of the Czech Medical Association of J. E. Purkyně (ČOS ČLS JEP) builds on intensive collaboration at all levels of medical care during the organisation of oncological care. Over 77,000 malignant neoplasms are diagnosed in the Czech Republic annually. Every year, over 27,000 patients with a malignant tumour die in the Czech Republic. A total of over 450,000 patients with malignant tumours or patients with a history of an oncological disease are living in the Czech Republic. The specialised society analyses available data about the treatment history and offers them to the individual regions; it also plans population based treatment costs which are then discussed with the healthcare payers. The Czech National Cancer Control Programme (NOP) presents a strategic outline for the management and development of the treatment, and facilitates the communication with all stakeholders and the public. The ČOS ČLS JEP Society includes a specialised section responsible for data analysis, which provides a complex agenda of population based data, estimated numbers of treated patients, standards for reference of survival analysis and a system of collecting required clinical data. Even with a growing incidence, the Czech Republic shows a stabilised mortality in all cancer diagnoses. Screening programmes for breast, colorectal and cervical carcinoma are ongoing. We have a consolidated and cooperating network of oncology centres. We are able to actively plan diagnostic and treatment needs and we have a system of data collection that is able to respond to the needs of evaluation of cost efficiency. We are currently introducing a hospital care quality assessment.